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Lamellar ichthyosis, one form of congenital auto-
somal recessive ichthyosis, is caused by mutations in
the gene (TGM1) encoding the transglutaminase 1
enzyme. Mutations, deletions, or insertion of TGM1
have been reported so far. Here we report that three
novel mutations of TGM1, D101V, N288T, and
R306W, cause lamellar ichthyosis in two different
families. The patient in family LI-KD has N288T and
R306W mutations, and the patient in family LI-LK
has D101V and R306W mutations. The activity of
the transglutaminase 1 enzyme of the patient in
family LI-LK was only about 15% of normal. Also,
three-dimensional structural prediction analyses
revealed that the N288T and R306W mutations, and
possibly the D101V mutation, cause misfolding in
the central catalytic core domain of the trans-
glutaminase 1 enzyme that would probably result in
reduced enzyme activity. Our data suggest that the
greatly reduced transglutaminase 1 activities are due
to disruptions of the native folding of transglutami-
nase 1, and that these mutations may play a critical
role in the pathology of lamellar ichthyosis. Key
words: lamellar ichthyosis/mutations/transglutaminase 1
gene. J Invest Dermatol 117:214±218, 2001
C
ongenital autosomal recessive ichthyoses are a
heterogeneous group of disorders that present at
birth with generalized involvement of skin and lack
of manifestations in other organ systems. There is no
consensus on the classi®cation of the autosomal
recessive ichthyoses subclasses, but depending on the ®ndings of
erythema two clinical subsets, lamellar ichthyosis (LI) and
nonbullous congenital ichthyosiform erythroderma, were distin-
guished by Williams and Elias (1985). LI is apparent at birth, and
the newborn often presents encased in a collodion membrane that
desquamates during the ®rst 10±14 d of life. Over time, the skin
forms large, dark, plate-like scales. Many patients also exhibit
ectropion and eclabian due to tautness of the facial skin. Scarring
alopecia on the scalp and eyebrow is a common sequela.
Histopathologic ®ndings show orthokeratotic hyperkeratosis and
mild to moderate acanthosis. The estimated incidence of LI is
1:200,000±300,000.
Transglutaminases (TGases) constitute a family of Ca2+ and
sulfhydryl-dependent enzymes that catalyze the formation of
isopeptide cross-links in proteins between the g-amide of a donor
glutamine residue and an e-NH2 group of an acceptor lysine
residue (Folk, 1980; Greenberg et al, 1991; Melino et al, 2000).
This cross-link thus contributes to the formation of a highly
insoluble macromolecular structure. Of the nine known different
members of the TGase family in human, at least ®ve are expressed
in the epidermis, and two have proven functions in the formation
of the cell envelope barrier structure (Steinert, 2000): the
membrane-associated TGase 1, which is expressed throughout
the epidermis and is involved in both cross-link formation and
ester-linkage of ceramides to cell envelope proteins; and the
cytosolic TGase 3, known to be expressed in the granular layer of
the epidermis and hair follicle. Both enzymes require proteolytic
activation at conserved sites to achieve optimal enzyme activity.
Russell et al (1994) reported that the likely causative gene defect
in LI in some families mapped to chromosome 14q11 near the
TGM1 locus encoding the TGase 1 enzyme, and subsequently
mutations in TGM1 were identi®ed (Huber et al, 1995; Russell
et al, 1995). Since then, several different mutations of TGM1 have
been identi®ed (Parmentier et al, 1995; Huber et al, 1997; Laiho
et al, 1997; Petit et al, 1997; Schorderet et al, 1997; Bichakjian et al,
1998; Hennies et al, 1998a; 1998b; Shevchenko et al, 2000). Later,
a second locus, at chromosome 2q33±35, was identi®ed in families
from Morocco (Parmentier et al, 1996). The existence of additional
families apparently unlinked to either TGM1 or chromosome 2q
suggests that at least one additional gene can cause LI (Bale et al,
1996; Parmentier et al, 1996). These ®ndings suggest that LI is
genetically heterogeneous.
In this paper, we report three novel mutations in TGM1 in two
LI patients, N288T (exon 5) and R306W (exon 6) in one patient,
and D101V (exon 2) and R306W in the other patient.
MATERIALS AND METHODS
Family LI-KD The proband (II-1) is a Japanese girl who was born
prematurely (38 wk) in 1996 from unaffected nonconsanguineous
parents. The newborn was encased in a translucent collodion membrane.
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At 24 h after birth, the collodion membrane began to dry and ectropion
and eclabium appeared. At 7 d after birth, the collodion membrane
began to peel off and the skin was slightly erythrodermic. At 1 mo of
age, the dry collodion membrane peeled off and large, slightly brownish
scales appeared, mainly on her trunk. Other body sites appeared near
normal, although the skin was dry. Ectropion and eclabium had reduced
by this time. At 6 mo, the brownish scales turned into ®ne, white scales.
Since then, the girl has been successfully controlled with petroleum.
Family LI-LK The clinical history of the patient (II-2) in this family
is very similar to that of patient LI-KD. The proband is a Korean boy
who was born in 1999 from unaffected nonconsanguineous parents. The
newborn was encased in a translucent collodion membrane, and was
placed in an incubator at the local hospital to control the skin problem.
At 24 h after birth, the collodion membrane began to dry and ectropion
and eclabium appeared. At about 1 mo of age, the dry collodion
membrane peeled off and large, slightly brownish scales appeared on his
trunk, buttocks, and face. Both extremities appeared near normal,
although the skin was dry. Ectropion and eclabium had reduced by this
time. The brownish large thick scales improved slowly with age and are
now con®ned to forehead, buttocks, and ¯ank.
Source of DNA Genomic DNA was isolated as described earlier
(Yang et al, 1994) from freshly drawn blood from both affected and
unaffected family members. Genomic DNA was also extracted from 50
unrelated individuals from the normal Korean population for use as
controls.
Direct polymerase chain reaction (PCR) ampli®cation of TGM1
and DNA sequencing The oligonucleotide primers and the
conditions of PCR used for amplifying all TGM1 exons, and subsequent
DNA sequencing, have been described previously (Russell et al, 1995). A
second reampli®cation reaction was required for exons 2, 5, and 6.
Screening assay for TGM1 mutations We used the assays to
facilitate the detection of each identi®ed mutation of the patient and to
screen for the occurrence of that mutation in the normal population.
The R306W substitution destroys an Msp I restriction enzyme site (C/
CGG) in DNA ampli®ed from exon 6. Completed PCR products were
puri®ed from the gel and digested with 2 units of Msp I for 2±4 h, and
analyzed on 6% polyacrylamide gels. As the D101V and N288T
substitutions did not destroy or create restriction enzyme sites, a PCR
ampli®cation of speci®c alleles (PASA) assay was developed for each
using two sets of speci®c wild-type and mutant primers. The mutant
primers differ only at the extreme 3¢-end and have the nucleotide change
complementary to the identi®ed mutation in TGM1. Ampli®ed products
were then characterized as before (Yang et al, 1994).
Molecular modeling A three-dimensional model of human TGase 1
was generated on the basis of the known atomic structure of human
factor XIIIa (fXIIIa) as search model as present in the Protein Data Bank
with accession code 1GGT (Bernstein et al, 1997). The modeling
packages INSIGHT-II and the Program O (Jones et al, 1991) were used
to build the model of TGase 1. The structurally aligned sequence of
TGase 1 residues was inscribed onto the structural frame provided by
fXIIIa residues from 231 to 319 for the R306W mutation, and residues
206±295 and 663±680 for the N288T mutation. The resulting model of
TGase 1 was then optimized at the positions where mutation or
nonconservative substitutions occurred. The stereo representation was
made with the program Molscript (Kraulis, 1991) and rendered using
Raster 3D (Merritt and Murphy, 1994). The D101V mutation cannot be
modeled as the equivalent region in fXIIIa has not been solved.
TGase 1 activity from cultured keratinocytes from family LI-
LK Keratinocytes were cultured from skin biopsies obtained from
father, mother, and patient of the LI-LK family as described by
Rheinwald and Green (1975). TGase 1 activity was measured from
cultured keratinocytes of LI-LK family members using a method adapted
from Lichti et al (1985). In brief, cells were lyzed by sonication in
20 mM sodium phosphate (pH 7.2), 0.5 mM ethylenediamine tetraacetic
acid, 10 mM dithiothreitol, and 50 mg per ml phenylmethylsulfonyl
¯uoride. After centrifugation at 25,000 3 g at 4°C for 30 min, the
supernatant was used as the cytosolic fraction. The pellet was re-
extracted by sonication with the same buffer plus 1% Triton X-100.
After incubation for 10 min at 37°C, the lysate was centrifuged again
and the supernatant was taken as the membrane fraction. TGase 1
activity was expressed as picomoles 3H-putrescine incorporated into
dimethylcaseine per hour and per milligram of protein. Results are
indicated as the mean 6 SE in cell extracts from at least two different
cell passages, each measured in triplicate.
Northern blot analysis Total RNA was extracted from cultured
keratinocytes using TRIzol (Gibco BRL) according to the
manufacturer's instructions. Ten micrograms of total RNA from each
sample were separated through a 1% agarose gel containing 2 M
formaldehyde, transferred to an H-bond nitrocellulose membrane
(Amersham), and hybridized for 24 h at 42°C to cDNA probe of TGase
1 radiolabeled with a32P-dCTP. The membrane was washed twice for
30 min at 23°C in a solution containing 2 3 sodium citrate/chloride
buffer (SSC) and 0.1% sodium dodecyl sulfate (SDS) and then for
30 min at 60°C with 0.2 3 SSC and 0.1% SDS. The blots were exposed
for 48 h at ±70°C. Rehybridization with a32P-dCTP labeled
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) probe was used to
normalize the relative amount of mRNA transcripts.
Figure 1. DNA sequences of TGM1. (a) The carrier mother (I-2)
and the patient (II-1) of family LI-KD have an A to C change, which
results in N288T substitution in exon 5. (b) The carrier father (I-1) and
the patient (II-1) of family LI-KD have a C to T substitution, which
results in R306W substitution in exon 6. (c) The mother (I-2) and
patient (II-2) of family LI-LK have an A to T change, which results in
D101V substitution in exon 2.
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RESULTS AND DISCUSSION
Identi®cation of TGM1 mutations To identify the mutations
within TGM1, all 15 exons and ¯anking intron sequences were
ampli®ed by PCR and were directly sequenced. The numbering of
basepairs and amino acids is according to Kim et al (1992).
Family LI-KD We found two missense mutations in the patient
of this family: an A to C transition in exon 5, resulting in the
substitution of threonine for asparagine (AAC to ACC) at the
amino acid position 288 (N288T), and a C to T transition in exon
6, resulting in the substitution of tryptophan for arginine (CGG to
TGG) at the amino acid position 306 (R306W). The ®rst mutation
is from her mother, and the second mutation is from her father
(Fig 1a, b). The R306W substitution destroys an Msp I restriction
enzyme site (C/CGG), but there are two Msp I enzyme sites in
exon 6 of TGM1. Three different sized bands (119 bp, 112 bp, and
48 bp) can be seen after enzyme digestion of the PCR products of
the wild-type allele. The mutation destroys one enzyme site, so that
a 167 bp (119 bp + 48 bp) band is seen in persons who have the
mutant allele (data not shown). More than 50 other normal
individuals did not have this band. As the N288T substitution does
not create or destroy any restriction enzyme site, we performed the
PASA assay to selectively amplify the wild-type allele or allele
carrying the mutation. Only the persons who have the mutant allele
(II-1 and I-2) give a 186 bp PCR product with both the mutant
and wild-type speci®c primers (data not shown). Because the father
and 50 other unrelated unaffected persons do not yield this PCR
product with mutant primer, the A to C substitution represents a
new mutation.
Family LI-LK We again found two missense mutations: the same
R306W in exon 6, and an A to T transition in exon 2, resulting in
the substitution of valine for aspartic acid (GAT to GTT) at the
amino acid position 101 (D101V). The ®rst mutation is from his
father, and the second mutation is from his mother (Fig 1c). As the
D101V substitution does not create or destroy any restriction
enzyme site, we performed the PASA assay to selectively amplify
the wild-type allele or allele carrying the mutation. Only the
persons who have the mutant allele (I-2 and II-2) give a 374 bp
PCR product with both the mutant and wild-type speci®c primers
(data not shown). Because the father and 50 other unrelated
unaffected persons do not yield this PCR product with mutant
primer, the A to T substitution represents a new mutation.
Modeling of the mutations Using the solved structure of the
related fXIIIa TGase enzyme, we have modeled the three
mutations reported here to explore their structural/functional
consequences.
R306W substitution This residue is conserved in the core domain
of all TGase enzymes and is R244 in fXIIIa. The guanidinium side
chains are involved in a network of H-bonds with E272 and Y240,
which in turn are connected to E306 (Fig 2, upper pair of stereo
images). These are structurally equivalent to isosteric N334 and
Y302 in TGase 1; in addition, E306 in fXIIIa is replaced by G368
in TGase 1. Thus in the R306W substitution of TGase 1, the
Figure 2. Stereo modeling images of the
R306W substitution. Upper panels: Wild-type
fXIIIa showing that the conserved R244 (R306 in
TGase 1) forms a network of H-bonds with E272
(isosteric with N334 in TGase 1), Y240 (Y302 in
TGase 1), and E306 (replaced by G368 in TGase
1). Lower panels: In the mutant TGase 1, the W
residue can make only one H-bond, resulting in a
probable substantial reduction of stability at this
point in the catalytic core domain.
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W306 is more bulky and only one H-bond can be made with N334
(Fig 2, lower pair). Together with the wild-type G368, it is to be
expected that this region will exhibit considerably more ¯exibility,
which might loosen the structural integrity of the catalytic core
domain at this point, with probably signi®cantly reduced activity.
N288T substitution In fXIIIa, the two residues S226 (structurally
isosteric with N288 in TGase 1) and T293 (replaced by V355 in
wild-type TGase 1) in the catalytic core domain are involved in
forming an H-bonding bridge with D668 (isosteric with E728 in
TGase 1) of the b-barrel 2 domain (Fig 3, upper pair of stereo images).
Also, H-bonding occurs between D668 and the main chain
nitrogen of G669 (G729 in TGase 1) of the b-barrel 2 domain.
These interactions from separate antiparallel b-strands form a strong
network with the twisted b sheet core domain. The N288T
substitution will allow only one H-bonding interaction between
the core and b-barrel 2 domain (Fig 3, lower pair). Again, this is
likely to cause local destabilization of the structure that would
manifest as reduced enzyme activity.
D101V substitution The equivalent position does not exist in
fXIIIa and so cannot be modeled directly. We have noticed
previously, however (Candi et al, 1998), two sequence motifs
NAADDD (residues 54±59) and NAAGDG (residues 97±102) on
the membrane anchorage domain of TGase 1. These are closely
similar to NAAEDD (residues 20±25) on the activation peptide of
fXIIIa, which controls access to the active site on the catalytic
domain. In TGase 1 these regions have been predicted to fold back
onto the catalytic domain so that N97 and D101, for example,
could form a cluster of H-bonds with R314 (Candi et al, 1998), and
thereby facilitate subsequent proteolytic activation of TGase 1.
Therefore, it seems plausible that the D101V mutant might inhibit
proteolytic activation of TGase 1, resulting in severely diminished
activity.
TGase 1 activity from skin samples of family LI-LK We obtained
skin samples from members of the LI-LK family. Keratinocytes
were cultured and TGase 1 activity was measured. As expected,
most enzyme activity resides in the membrane fraction (Kim et al,
1994) (Table I). Both the cytosolic and membrane bound forms of
the TGase 1 activity were reduced in comparison to the normal
control. As shown the TGase 1 activities of the father (R306W),
mother (D101V), and the patient (R306W/D101V) were reduced
to around 50%, 50%, and 5%±15%, respectively, of controls from
the skin of normal individuals.
Figure 3. Stereo modeling images of the
N288T substitution. Upper panels: Wild-type
fXIIIa showing that S226 (isosteric with T288 in
TGase 1) forms a network of H-bonds with D668
(isosteric with E728 in TGase 1) and G669 (G729
in TGase 1) to stabilize interactions between the
catalytic core domain and the b-barrel 2 domain.
Lower panels: In the mutant TGase 1, only one H-
bond can be formed, resulting in a probable
reduced molecular stability between the two
protein domains.
Table I. Speci®c activities of TGase 1 in cultured
keratinocytes from family LI-LKa
Cytosolic activity Membrane activity
I-1 (R306W) 305.96 6 110.18 (56%) 1007.52 6 104.29 (52%)
I-2 (D101V) 284.07 6 92.63 (52%) 939.12 6 205.91 (48%)
II-2 (R306W/D101V) 82.32 6 42.12 (15%) 102.41 6 27.28 (5%)
aThe data are averages 6 SE of triplicate analyses.
Figure 4. Northern blot analysis. Ten micrograms of total RNA
hybridized with an a32P-dCTP labeled cDNA probe. TGase 1
transcripts in similar amounts were clearly detectable in mRNAs from
father (I-1), mother (I-2), and patient (II-2) of the LI-LK family, and in
a control (c).
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Northern blot analysis Northern blot analysis of total RNA from
cultured keratinocytes was performed for father (I-1), mother (I-2),
and patient (II-2) of the LI-LK family and a normal control. Both
parents and the patient demonstrated mRNA of normal size (2.9
kb) and in amounts comparable to the control (Fig 4). These
results were obtained after standardization by GAPDH
hybridization of the quantity of RNA present in each lane.
In summary, we have documented three novel mutations of the
TGM1 gene in two different LI families: N288T and R306W in
family LI-KD, and R306W and D101V in family LI-LK.
According to our molecular modeling analyses, each mutation is
likely to cause signi®cant destabilization or prevent activation of
TGase 1, leading to reduced activity of the enzyme. In family LI-
LK, both heterozygous parents, assuming both the wild-type and
mutant alleles are equally expressed, apparently retain suf®cient
activity to present a normal phenotype, and retain about 50% of
normal activity, suggesting that the TGase 1 enzyme produced
from each abnormal allele was mostly inactive. Indeed, the
simultaneous occurrence of both mutations in the same patient
reduced the net TGase 1 enzyme activity to about 15%, apparently
below a threshold level, resulting in an LI presentation. A similar
conclusion seems likely for the LI-KD family involving the novel
N288T mutation.
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